Ariceum Therapeutics

Ariceum Therapeutics is a private clinical-stage radiopharmaceutical company focused on the diagnosis and precision treatment of neuroendocrine and certain other aggressive, difficult-to-treat cancers. Ariceum Therapeutics is developing novel drugs for systemic targeted radionuclide therapy (STR).